-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Viking Therapeutics, Inc. annual Income Tax Expense (Benefit) history and growth rate from 2016 to 2023.
- Viking Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was $1 K, unchanged from 2022.
- Viking Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $1 K, a 50% decline from 2021.
- Viking Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was $2 K.
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)